OGN - Organon & Co.
6.9
-0.290 -4.203%
Share volume: 2,627,508
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$7.19
-0.29
-0.04%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-28-2025 | 05-02-2025 | 11-10-2025 | 02-24-2026 | |
| Assets | |||||
| Total Assets | 13.101 B | 13.156 B | 13.552 B | 12.867 B | |
| Current Assets | 4.348 B | 4.371 B | 4.700 B | 4.352 B | |
| Inventories | 1.321 B | 1.362 B | 1.488 B | 1.406 B | |
| Other Current Assets | 994.000 M | 1.005 B | 1.056 B | 1.033 B | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 675.000 M | 547.000 M | 672.000 M | 574.000 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.168 B | 1.197 B | 1.290 B | 1.303 B | |
| Other Assets | 7.585 B | 7.588 B | 7.562 B | 7.212 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 13.101 B | 13.156 B | 13.552 B | 12.867 B | |
| Total liabilities | 12.629 B | 12.614 B | 12.646 B | 12.115 B | |
| Total current liabilities | 2.718 B | 2.615 B | 2.679 B | 2.390 B | |
| Accounts Payable | 1.153 B | 1.006 B | 1.074 B | 952.000 M | |
| Other liabilities | 977.000 M | 994.000 M | 1.122 B | 1.008 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 8.860 B | 8.936 B | 8.783 B | 8.628 B | |
| Other liabilities | 977.000 M | 994.000 M | 1.122 B | 1.008 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 472.000 M | 542.000 M | 906.000 M | 752.000 M | |
| Common stock | 111.000 M | 133.000 M | 162.000 M | 170.000 M | |
| Retained earnings | 1.010 B | 1.026 B | 1.318 B | 1.109 B |